CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.
CHENGDU,China,Feb. 8,2025-- KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Dru
Introducing Revolutionary Smart Lock Technology Globally,Crafting a Smarter,Safer Future for Your Home
LAS VEGAS,Jan. 15,2025-- VOLTME,the flagship brand of Voltnex Innovations and a global leader in power solutions,has been honored with the 2024-2025 Global Emerging Brand Award for its revolutionary p
SHANGHAI,Jan. 15,2025-- Medtec,a comprehensive one-stop platform offering solutions for the design,R&D,and production of medical devices,has garnered widespread recognition and active participatio
Latest recognition makes IFS a Gartner Peer Insights Customers\' Choice across three categories: Field Service Management,Cloud ERP,and nowEAM.
